7 Key Considerations for In-House Validation of NGS-Based Assays

Genedata Selector

Next-generation sequencing (NGS) has revolutionized biopharma workflows, offering speed and accuracy in a GMP-compliant environment. However, in-house validation of NGS assays presents unique challenges, including variability in methods, instruments, and protocols, robust data handling, and regulatory compliance.

This brochure explores essential insights and strategies for successful NGS assay implementation in a validated environment. Equip your team with the knowledge to navigate these complexities and ensure reliable, compliant results.